â– LECTURE OVERVIEW: Nephrotic Syndrome represents a severe pattern of glomerular injury characterized by a dramatic increase in glomerular capillary wall permeability to plasma proteins.
â– PATHOPHYSIOLOGIC MECHANISMS:
1. Podocyte Foot Process Effacement: Glomerular basement membrane filtration barriers are disrupted, commonly due to podocyte injury or antigen complex deposition.
2. Massive Proteinuria: Loss of negative charge barriers causes massive, heavy proteinuria (>3.5 grams/24 hours).
3. Hypoalbuminemia: Hepatic protein synthesis cannot compensate for renal losses, dropping serum albumin below 3 g/dL.
4. Oncotic Pressure Loss: Lower intravascular oncotic pressure shifts fluid into the interstitium, triggering compensatory sodium retention that causes generalized edema (anasarca).
5. Hyperlipidemia: In response to hypoalbuminemia, the liver non-specifically upregulates lipoprotein synthesis, leading to hyperlipidemia and lipiduri (visible on microscopy as 'fatty casts' and maltese-cross lipid droplets).
â– PHARMACOKINETIC & PHARMACODYNAMIC ATTRIBUTES:
Absorption and steady-state kinetics display high variability based on plasma protein binding levels, tissue volume of distribution (Vd), and hepatic CYP450 microsomal enzymatic clearance indices.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1352]
🌟 Dynamic Clinical Key:
Urinary protein wasting is not limited to albumin. Wasting of Antithrombin-III (ATIII) creates a hypercoagulable state that carries a high risk of thromboembolism, particularly renal vein thrombosis, which presents as sudden flank pain and hematuria. Closely monitor serum plasma concentrations if drugs display a narrow therapeutic window to mitigate toxic peaks. Focus screening efforts on high-risk geographic regions to maximize clinical yield.